Pages without language links

Showing below up to 50 results in range #1 to #50.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

1. ADAMTS13, recombinant (Adzynma)
2. ASCO guidelines
3. Abarelix (Plenaxis)
4. Abciximab (ReoPro)
5. Abemaciclib (Verzenio)
6. Abexinostat (PCI-24781)
7. Abiraterone (Zytiga)
8. Academic Medicine exhibit
9. Academic Medicine standard narrative
10. Academic Medicine wiki-based narrative
11. Acalabrutinib (Calquence)
12. Acetaminophen (Tylenol)
13. Acetazolamide (Diamox)
14. Aclarubicin (Aclacinon)
15. Acquired hemophilia A
16. Acquired thrombotic thrombocytopenic purpura
17. Actinium Ac 225 lintuzumab (Actimab-A)
18. Acute lymphoblastic leukemia, infant
19. Acute lymphoblastic leukemia, infant - historical
20. Acute myeloid leukemia
21. Acute myeloid leukemia, FLT3-positive
22. Acute myeloid leukemia, FLT3-positive - null regimens
23. Acute myeloid leukemia, IDH-mutated
24. Acute myeloid leukemia, NPM1-mutated
25. Acute myeloid leukemia, pediatric
26. Acute myeloid leukemia, pediatric - historical
27. Acute myeloid leukemia - historical
28. Acute myeloid leukemia - null regimens
29. Acute myeloid leukemia trial demographics
30. Acute promyelocytic leukemia
31. Acute promyelocytic leukemia - null regimens
32. Acyclovir (Zovirax)
33. Adagrasib (Krazati)
34. Adavosertib (MK-1775)
35. Adebrelimab (SHR-1316)
36. Adrenocortical carcinoma
37. Adrenocortical carcinoma - null regimens
38. Adult T-cell leukemia-lymphoma
39. Adult T-cell leukemia-lymphoma - historical
40. Afamitresgene Autoleucel (ADP-A2M4)
41. Afatinib (Gilotrif)
42. Afuresertib (GSK-2110183)
43. Agatolimod (PF-3512676)
44. Aggressive Non-Hodgkin lymphoma
45. Aldesleukin (Proleukin)
46. Alectinib (Alecensa)
47. Alemtuzumab (Campath)
48. Alendronate (Fosamax)
49. Alisertib (MLN-8237)
50. Alitretinoin (Panretin)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)